Sarah Stabenfeldt received her bachelor's degree in biomedical engineering from Saint Louis University and her doctorate in bioengineering from Georgia Institute of Technology. She was awarded an National Institutes of Health (NIH) NRSA pre-doctoral fellowship for her doctoral thesis research on developing neural tissue engineering therapies for traumatic brain injury. As a NIH postdoctoral fellow at Emory University School of Medicine and Georgia Tech, she investigated fibrin-derived peptide-protein binding interactions, designing fibrin-based wound healing therapeutics. She joined Arizona State University’s School of Biological and Health Systems Engineering as an assistant professor in 2011 and leads her research team in developing regenerative medicine strategies for acute neural injury. Since joining ASU, Stabenfeldt has been awarded the Arizona Biomedical Research Consortium Early Stage Investigator Award, the NIH Director’s New Innovator Award, and a National Science Founcation (NSF) CAREER Award.